The deal is a victory for Trump who has pressured drugmakers to voluntarily comply with his policy priorities. If not, they will likely face regulation or high tariffs.
Source link
CRV Price Prediction: $0.36 Breakout Target as Retail Shorts Face June Squeeze
May 25, 2026
No Comments
